Procaps Group SA Total Assets

Latest as of September 2023: $498.55 Million USD

Procaps Group SA total assets. Based on the latest financial reports, Procaps Group SA (PROC) holds total assets worth $498.55 Million USD as of September 2023. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see PROC market cap for the company's overall valuation and market capitalisation.

Total Assets of Procaps Group SA (2019–2022)

Total assets of Procaps Group SA from 2019 to 2022. This chart illustrates how Procaps Group SA's total assets have evolved over time, based on quarterly financial data. See Procaps Group SA stock quote for real-time trading data and today's change.

Procaps Group SA - Asset Composition Analysis

Procaps Group SA Total Assets Breakdown (December 2022)

Procaps Group SA total assets breakdown as of December 2022. Procaps Group SA's total assets of $498.55 Million consist of 64.6% current assets and 35.4% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 9.3%
Accounts Receivable $153.26 Million 33.3%
Inventory $96.83 Million 21.0%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $32.21 Million 7.0%
Goodwill $5.79 Million 1.3%

Asset Composition Trend (2019–2022)

This chart illustrates how Procaps Group SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Procaps Group SA's working capital to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Procaps Group SA's current assets represent 64.6% of total assets in 2022, an increase from 51.1% in 2019.
  • Cash Position: Cash and equivalents constituted 9.3% of total assets in 2022, up from 0.6% in 2019.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, unchanged from 8.0% in 2019.
  • Asset Diversification: The largest asset category is accounts receivable at 33.3% of total assets.

Procaps Group SA Competitors by Total Assets

Key competitors of Procaps Group SA based on total assets are shown below.

Company Country Total Assets
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
China CN¥68.33 Billion
Sandoz Group AG
SW:SDZ
Switzerland CHF22.86 Billion
H Lundbeck A/S
CO:HLUN-B
Denmark Dkr54.01 Billion
Changchun High & New Technology Industries Group Inc
SHE:000661
China CN¥30.77 Billion
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
China CN¥17.01 Billion
Kangmei Pharmaceutical Co Ltd
SHG:600518
China CN¥13.68 Billion
Viyash Scientific Limited
NSE:SEQUENT
India Rs17.26 Billion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥5.11 Billion

Procaps Group SA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.47 1.38 0.69
Quick Ratio 0.99 0.93 0.43
Cash Ratio 0.00 0.00 0.00
Working Capital $95.42 Million $83.91 Million $-19.01 Million

Procaps Group SA - Advanced Valuation Insights

This section examines the relationship between Procaps Group SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 64.34
Latest Market Cap to Assets Ratio 0.25
Asset Growth Rate (YoY) -0.4%
Total Assets $460.19 Million
Market Capitalization $113.95 Million USD

Valuation Analysis

Below Book Valuation: The market values Procaps Group SA's assets below their book value (0.25x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Procaps Group SA's assets decreased by 0.4% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Procaps Group SA (2019–2022)

The table below shows the annual total assets of Procaps Group SA from 2019 to 2022.

Year Total Assets Change
2022-12-31 $460.19 Million -0.42%
2021-12-31 $462.13 Million +28.54%
2020-12-31 $359.54 Million +6.46%
2019-12-31 $337.73 Million --

About Procaps Group SA

NASDAQ:PROC USA Drug Manufacturers - Specialty & Generic
Market Cap
$124.11 Million
Market Cap Rank
#18493 Global
#4320 in USA
Share Price
$1.10
Change (1 day)
+0.00%
52-Week Range
$1.10 - $1.10
All Time High
$10.76
About

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use… Read more